The tissue renin-angiotensin-aldosterone system in diabetes mellitus-Reference-Cited by-同舟云学术

The tissue renin-angiotensin-aldosterone system in diabetes mellitus

Published:2004-04 Issue:2 Volume:6 Page:98-105
ISSN:1522-6417
Container-title:Current Hypertension Reports
language:en
Short-container-title:Current Science Inc

Author:

Hanes Donna S.,Nahar Anita,Weir Matthew R.

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11906-004-0083-8.pdf

Reference60 articles.

1. Harris M: Health care and health care status and outcomes for patients with type 2 diabetes. Diabetes Care 2000, 23:754–758.

2. US Renal Data System: USRDS 1999 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1999:25–38.

3. Arauz-Pacheco C, Parrott MA, Raskin P: Treatment of hypertension in adults with diabetes. Diabetes Care 2003, 26:S80-S82.

4. Lewis EJ, Hunsicker LG, Clark WR, et al.: Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001, 345:851–886. Large clinical trial demonstrating the superior risk reduction of hard renal end points using ARB versus calcium-blocker therapy in type 2 diabetes.

5. Brenner BM, Cooper ME, de Zeeuw D, et al.: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001, 345:861–869. Large clinical trial demonstrating significant reduction of hard renal end points with ARB therapy in type 2 diabetes.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Losartan a Promising Agent for the Treatment of Type 1 Diabetes-Induced Testicular Germ Cell Apoptosis in Rats?;2022-11-02

2. The Association between Angiotensin II Type 1 Receptor Gene A1166C Polymorphism and Non-alcoholic Fatty Liver Disease and Its Severity;Middle East Journal of Digestive Diseases;2018-03-23

3. Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye;Investigative Opthalmology & Visual Science;2016-12-12

4. Combined Renin Inhibition/(Pro)Renin Receptor Blockade in Diabetic Retinopathy- A Study in Transgenic (mREN2)27 Rats;PLoS ONE;2014-06-26

5. Pathogenesis of Diabetic Nephropathy: Hemodynamic Alterations/Renin Angiotensin System;Diabetes and Kidney Disease;2014